Stabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS

Santiago Mora, Anna Stuckert, Rasmus von Huth Friis, Kimberly Pietersz, Gith Noes-Holt, Roser Montañana-Rosell, Haoyu Wang, Andreas Toft Sørensen, Raghavendra Selvan, Joost Verhaagen, Ilary AllodiNature Communications 2024 · OpenReview

Abstract

Loss of connectivity between spinal V1 inhibitory interneurons and motor neurons is found early in disease in the SOD1<sup>G93A</sup> mice. Such changes in premotor inputs can contribute to homeostatic imbalance of motor neurons. Here, we show that the Extended Synaptotagmin 1 (Esyt1) presynaptic organizer is downregulated in V1 interneurons. V1 restricted overexpression of Esyt1 rescues inhibitory synapses, increases motor neuron survival, and ameliorates motor phenotypes. Two gene therapy approaches overexpressing ESYT1 were investigated; one for local intraspinal delivery, and the other for systemic administration using an AAV-PHP.eB vector delivered intravenously. Improvement of motor functions is observed in both approaches, however systemic administration appears to significantly reduce onset of motor impairment in the SOD1<sup>G93A</sup> mice in absence of side effects. Altogether, we show that stabilization of V1 synapses by ESYT1 overexpression has the potential to improve motor functions in ALS, demonstrating that interneurons can be a target to attenuate ALS symptoms.

Introduction

Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease characterized by the death of motor neurons (MNs), leading to progressive paralysis. While research often focuses on the motor neurons themselves, emerging evidence suggests that "upstream" changes in premotor circuitry play a critical role. Specifically, V1 inhibitory interneurons, which regulate MN activity, lose their synaptic connections early in the disease progression. This loss of inhibitory input leads to MN hyperexcitability and eventual excitotoxicity. This study identifies the downregulation of Extended Synaptotagmin 1 (Esyt1), a presynaptic organizer, as a key driver of this synaptic detachment.

Methods

The study utilized the SOD1<sup>G93A</sup> mouse model of ALS. To specifically target V1 interneurons, the researchers used En1<sup>cre</sup> mice. They employed RNAscope and immunohistochemistry to quantify Esyt1 levels. Therapeutic intervention involved engineering Adeno-associated viruses (AAVs) to overexpress human ESYT1. Two delivery routes were compared: local intraspinal delivery (AAV8) and systemic intravenous delivery (AAV-PHP.eB), the latter of which can cross the blood-brain barrier. Motor performance was evaluated using high-resolution kinematic analysis via DeepLabCut and longitudinal treadmill gait monitoring.

Results

A primary discovery was the significant and progressive downregulation of Esyt1 transcripts in V1 interneurons of SOD1<sup>G93A</sup> mice compared to wild-type (WT) controls.

Figure g: Quantification of ESYT1 transcript levels in En1-positive cells demonstrates significant downregulation in the SOD1 model at P63 and P84 compared to wild-type.

Restoring Esyt1 levels through gene therapy successfully stabilized inhibitory synapses (Vgat+) on motor neurons. This "synaptic rescue" translated into significant functional improvements. Systemic administration of AAV-PHP.eB-ESYT1 was particularly effective, delaying the onset of motor impairment; at P112, 75% of treated ALS mice showed no motor deficits, whereas 100% of untreated ALS mice had already failed.

Figure f: Representative image showing Esyt1 (orange) and En1 (cyan) expression in the spinal cord of a SOD1 mouse, illustrating the molecular targets of the study.

Treated mice exhibited improved weight support, faster walking speeds, and reduced hindlimb hyperflexion. Furthermore, there was a significant increase in the survival of large motor neurons in the lumbar spinal cord at the disease end-stage.

Discussion

This research demonstrates that stabilizing the circuitry surrounding motor neurons is a viable strategy for treating ALS symptoms. Esyt1 acts as a "synaptic glue" that maintains the inhibitory "brakes" on motor neurons, preventing excitotoxic death. While the treatment did not extend the overall lifespan of the mice—likely because it does not address the systemic metabolic decline associated with ALS—it significantly improved quality of life through preserved motor function. These findings suggest that interneurons are a promising target for future ALS therapies, potentially in combination with treatments addressing other aspects of the disease.

Summary updated

Abstract

<p>Loss of connectivity between spinal V1 inhibitory interneurons and motor neurons is found early in disease in the SOD1<sup>G93A</sup> mice. Such changes in premotor inputs can contribute to homeostatic imbalance of motor neurons. Here, we show that the Extended Synaptotagmin 1 (Esyt1) presynaptic organizer is downregulated in V1 interneurons. V1 restricted overexpression of Esyt1 rescues inhibitory synapses, increases motor neuron survival, and ameliorates motor phenotypes. Two gene therapy approaches overexpressing ESYT1 were investigated; one for local intraspinal delivery, and the other for systemic administration using an AAV-PHP.eB vector delivered intravenously. Improvement of motor functions is observed in both approaches, however systemic administration appears to significantly reduce onset of motor impairment in the SOD1<sup>G93A</sup> mice in absence of side effects. Altogether, we show that stabilization of V1 synapses by ESYT1 overexpression has the potential to improve motor functions in ALS, demonstrating that interneurons can be a target to attenuate ALS symptoms.</p>
BibTeX
@inproceedings{mora2024stabilization,
  author = {Santiago Mora and Anna Stuckert and Rasmus von Huth Friis and Kimberly Pietersz and Gith Noes-Holt and Roser Montañana-Rosell and Haoyu Wang and Andreas Toft Sørensen and Raghavendra Selvan and Joost Verhaagen and Ilary Allodi},
  title = {{Stabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS}},
  booktitle = {Nature Communications},
  year = {2024},
  url = {https://openreview.net/forum?id=ni2gUhVBB6},
}
Figure